INTUITIVE SURGICAL INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations $1.3b $1.8b $2.3b $2.9b
Net Income (Loss) Attributable to Parent $735.9m $660.0m $1.1b $1.4b $1.1b $1.7b $1.3b $1.8b $2.3b $2.9b
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $1.1b $1.4b $1.1b $1.7b $1.3b $1.8b $2.3b $2.9b
Net Income (Loss) Attributable to Noncontrolling Interest $400k ($2.9m) $2.5m $6.2m $23.5m $22.1m $19.3m $14.9m $20.6m
Depreciation $70.7m $82.1m $105.9m $156.7m $220.6m $280.0m $326.0m $382.0m $439.0m $600.0m
Amortization of Intangible Assets $18.2m $12.9m $14.2m $43.0m $49.8m $27.4m $27.8m $20.2m $16.7m $13.2m
Amortization Cash Flow $27.8m $53.2m $54.4m $62.4m
Amortization Of Intangibles $27.8m $53.2m $54.4m $62.4m
Depreciation Amortization Depletion $365.8m $454.8m $499.7m $677.1m
Deferred Income Tax Expense (Benefit) $19.1m $62.7m $34.0m ($6.1m) $57.6m ($64.0m) ($185.3m) ($280.8m) ($135.3m) $19.1m
Deferred Income Tax ($185.3m) ($280.8m) ($135.3m) $19.1m
Deferred Tax ($185.3m) ($280.8m) ($135.3m) $19.1m
Share-based Payment Arrangement, Noncash Expense $177.6m $209.1m $261.2m $335.8m $395.4m $449.2m $513.2m $592.8m $676.8m $788.2m
Payment, Tax Withholding, Share-based Payment Arrangement $24.0m $56.6m $120.0m $159.1m $175.2m $211.6m $194.2m $164.7m $270.0m $419.1m
Share-based Payment Arrangement, Expense $178.0m $209.9m $262.6m $337.9m $398.7m $456.8m $516.5m $598.2m $688.1m $802.8m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0
Gain (Loss) on Disposition of Business $3.8m $0 $1.1m $1.0m
Income Tax Expense (Benefit) $244.9m $436.5m $154.5m $120.4m $140.2m $162.2m $262.4m $141.6m $336.3m $434.8m
Operating Lease, Expense $19.1m $21.0m $20.4m $25.7m $26.8m $33.9m $40.9m
Operating Lease, Lease Income $106.9m $176.7m $276.9m $376.5m $500.5m $654.2m $874.3m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $35.9m $81.7m $161.3m ($38.8m) ($5.7m) $142.3m $159.3m $186.3m $95.9m $301.7m
Increase (Decrease) in Inventories $46.7m $115.5m $279.0m $360.5m $170.1m $256.0m $546.6m $712.5m $830.0m $1.1b
Increase (Decrease) in Accounts Payable $15.9m $14.0m $16.7m $12.3m ($32.3m) $36.0m $21.3m $41.7m ($400k) $57.9m
Foreign Currency Transaction Gain (Loss), before Tax ($5.6m) $9.7m ($2.6m) ($1.5m) $10.9m ($16.4m) ($54.2m) ($8.5m) ($45.9m) ($7.5m)
Gain (Loss) Related to Litigation Settlement $42.5m $42.5m
Goodwill $201.1m $201.1m $240.6m $307.2m $336.7m $343.6m $348.5m $348.7m $347.5m $370.3m
Nonoperating Income (Expense) $35.6m $41.9m $80.1m $127.7m $157.2m $69.3m $29.7m $192.1m $324.9m $365.9m
Operating Expenses $944.9m $1.1b $1.4b $1.7b $1.8b $2.1b $2.6b $3.0b $3.3b $3.7b
Realized Investment Gains (Losses) $0 $0
Unrealized Gain (Loss) on Investments $35.9m $21.2m $1.8m $20.4m $29.5m $16.0m ($154.2m) ($29.7m) $0 $0
Beginning Cash Position $1.3b $1.6b $2.8b $2.1b
Cash Flow From Continuing Financing Activities ($2.6b) ($287.6m) $150.9m ($2.4b)
Cash Flow From Continuing Investing Activities $1.4b ($360.1m) ($3.3b) $665.8m
Change In Account Payable $21.3m $41.7m ($400k) $57.9m
Change In Inventory ($546.6m) ($712.5m) ($830.0m) ($1.1b)
Change In Other Current Liabilities $121.7m ($32.9m) $108.3m $34.1m
Change In Other Working Capital $73.0m $88.2m $130.5m $187.9m
Change In Payable $21.3m $41.7m ($400k) $57.9m
Change In Payables And Accrued Expense $21.3m $41.7m ($400k) $57.9m
Change In Prepaid Assets ($129.2m) $24.2m ($231.8m) ($187.1m)
Change In Receivables ($159.3m) ($186.3m) ($95.9m) ($301.7m)
Change In Working Capital ($619.1m) ($777.6m) ($919.3m) ($1.3b)
Changes In Account Receivables ($159.3m) ($186.3m) ($95.9m) ($301.7m)
Changes In Cash $289.3m $1.2b ($706.9m) $1.3b
End Cash Position $1.6b $2.8b $2.1b $3.4b
Financing Cash Flow ($2.6b) ($287.6m) $150.9m ($2.4b)
Free Cash Flow $958.4m $749.6m $1.3b $2.5b
Gain Loss On Investment Securities $49.0m $7.3m ($43.3m) ($57.2m)
Gain Loss On Sale Of Business ($3.8m) $0 ($1.1m) ($1.0m)
Investing Cash Flow $1.4b ($360.1m) ($3.3b) $665.8m
Net Business Purchase And Sale ($12.8m) ($8.9m) ($1.0m) ($13.9m)
Net PPE Purchase And Sale ($532.4m) ($1.1b) ($1.1b) ($539.8m)
Operating Gains Losses $45.2m $7.3m ($44.4m) ($58.2m)
Other Non Cash Items $22.0m $26.6m $33.0m $37.7m
Proceeds From Stock Option Exercised $233.8m $296.3m $429.4m $350.3m
Purchase Of Business ($12.8m) ($8.9m) ($1.0m) ($13.9m)
Purchase Of PPE $53.9m $190.7m $187.4m $425.6m $341.5m $353.5m ($532.4m) ($1.1b) ($1.1b) ($539.8m)
Repurchase Of Capital Stock ($2.6b) ($416.3m) $0 ($2.3b)
Stock Based Compensation $513.2m $592.8m $676.8m $788.2m
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax $600k ($1.2m) $1.0m $5.3m $2.8m
Net Cash Provided by (Used in) Operating Activities $1.0b $1.1b $1.2b $1.6b $1.5b $2.1b $1.5b $1.8b $2.4b $3.0b
Cash flows from investing activities:
Capital Expenditure ($532.4m) ($1.1b) ($1.1b) ($539.8m)
Payments to Acquire Businesses, Net of Cash Acquired $87.9m $59.7m $37.7m $8.7m $12.8m $8.9m $1.0m $13.9m
Net Investment Purchase And Sale $1.9b $713.0m ($2.2b) $1.2b
Purchase Of Investment ($1.4b) ($2.2b) ($5.1b) ($1.2b)
Sale Of Investment $3.3b $2.9b $3.0b $2.4b
Net Cash Provided by (Used in) Investing Activities ($1.3b) $378.7m ($1.0b) ($1.2b) ($940.6m) ($2.5b) $1.4b ($360.1m) ($3.3b) $665.8m
Cash flows from financing activities:
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $970.1m $703.1m $1.5b $2.6b $2.9b $4.3b $3.3b $2.7b $2.9b $2.2b
Net Common Stock Issuance ($2.6b) ($416.3m) $0 ($2.3b)
Payments for Repurchase of Common Stock $42.5m $2.3b $0 $269.5m $134.3m $0 $2.6b $416.3m $0 $2.3b
Common Stock Payments ($2.6b) ($416.3m) $0 ($2.3b)
Proceeds from Noncontrolling Interests $2.0m $10.0m $10.0m $0 $0
Proceeds from (Payments for) Other Financing Activities $0 $2.0m $9.7m
Net Other Financing Charges ($198.7m) ($167.6m) ($278.5m) ($419.1m)
Net Cash Provided by (Used in) Financing Activities $558.5m ($1.9b) $126.3m ($168.4m) ($85.7m) $43.0m ($2.6b) ($287.6m) $150.9m ($2.4b)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0 $2.1m ($100k) ($2.2m) ($2.6m) ($3.4m) $5.4m $3.3m ($800k) $12.8m
Effect Of Exchange Rate Changes $5.4m $3.3m ($800k) $12.8m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $0 $2.1m ($100k) $273.2m $455.9m ($332.5m) $294.7m $1.2b ($707.7m) $1.3b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0 $2.1m $909.4m $1.2b $1.6b $1.3b $1.6b $2.8b $2.1b $3.4b
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $294.7m $1.2b ($707.7m) $1.3b
Income Taxes Paid, Net ($24.0m) ($56.6m) ($120.0m) ($159.1m) ($175.2m) ($211.6m) ($194.2m) ($164.7m) ($270.0m) $537.9m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.